Plasma Exchange And Glucocorticoids In ANCA Associated Vasculitis: A Randomised Controlled Trial (PEXIVAS Australia)
Funder
National Health and Medical Research Council
Funding Amount
$635,243.00
Summary
Vasculitis is a life-threatening disease, and the current treatment for this condition is not satisfactory. This clinical trial aims to determine 1) if plasma exchange can lower mortality and the development of severe kidney failure due to this disease, and 2) if the use of lower doses of corticosteroids can lessen the infectious complications of treatment. This trial is part of a major international effort which will involve a total of 500 patients from Australia, UK, Europe, USA and NZ.
Role Of Adhesion Molecules In Autoimmune Vasculitis
Funder
National Health and Medical Research Council
Funding Amount
$377,036.00
Summary
Lupus is a disease which causes inflammation and pain throughout the body. The inflammation is caused by white blood cells attacking the lining of blood vessels in tissues. The aim of this project is to understand the reasons why these white blood cells attack the blood vessel lining. This process is impossible to study in humans. However, there is a strain of mouse which is affected by a disease which is very similar to human lupus. This disease occurs spontaneously in these mice. Using a micro ....Lupus is a disease which causes inflammation and pain throughout the body. The inflammation is caused by white blood cells attacking the lining of blood vessels in tissues. The aim of this project is to understand the reasons why these white blood cells attack the blood vessel lining. This process is impossible to study in humans. However, there is a strain of mouse which is affected by a disease which is very similar to human lupus. This disease occurs spontaneously in these mice. Using a microscope, it is possible to study the tiny blood vessels which are affected by this disease in these mice . Under the microscope, it is possible to see the white blood cells as they undergo the process of attacking the blood vessel lining. Visualizing this attack then allows us to study it and determine which molecules are important in causing this damaging inflammatory response. Specifically I will examine diseased blood vessels in the skin and brain of these mice, two of the tissues most dramatically affected by this disease. This information should help us gain an increased understanding of lupus as it affects humans.Read moreRead less
Immunoregulation In The Pathogenesis And Therapy Of Autoimmune Anti Myeloperoxidase Glomerulonephritis
Funder
National Health and Medical Research Council
Funding Amount
$283,880.00
Summary
Glomerulonephritis (GN) is a major health burden and crescentic GN is the most severe form. Most patients have autoantibodies to their own white blood cell ANCA, causing the disease. This study will use a mouse model of ANCA associated autoimmunity causing crescentic GN to define the normal mechanisms preventing the development of this disease (immunoregulation) and test the potential of new cell based therapies to prevent and treat the disease.
Mechanisms Of Disease In Humans With MPO-ANCA Associated Glomerulonephritis
Funder
National Health and Medical Research Council
Funding Amount
$533,541.00
Summary
Glomerulonephritis (GN) is a major health burden and crescentic GN is the most severe form. Most patients have autoantibodies to their own white blood cell ANCA, causing the disease. This study plans to assess immune cells and kidney biopsies from patients with anti-MPO GN to define more precisely the immune mechanisms causing disease.
Invasive Assessment Of Pulmonary Vascular Physiology - Novel Methods For Early Detection Of Pulmonary Vascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$274,352.00
Summary
Pulmonary vascular disease (PVD) is a lethal condition characterised by progressive destruction of the lung blood vessels. One major problem with PVD is that diagnosis is often made very late in the illness, when the pulmonary blood pressure rises. This project aims to develop a novel method to detect the early and clinically silent phase of PVD, by assessing the lung's blood vessel reserves. Early diagnosis of PVD will enable earlier treatment thereby improving prospects for treatment.